CSF2 and myasthenia gravis: They observed a decreased proportion of two CD4+ T subpopulations: effector memory CD4+ T cells expressing GM-CSF, especially in newly diagnosed treatment-naïve MG patients with highly active disease, and CD103+CD4+ T cells described as tissue-resident T cells re-entering the circulation (14).